Email Jun 12, 2021
The Next Investors weekly wrap up, covering off everything that happened in our portfolio this week.
Email Jun 11, 2021
Creso Pharma (ASX:CPH) today announced its listing in the US, and the market is opening in around 12 hours - the US pool of investors is huge and they have a big appetite for psychedelics and cannabis stocks.
Email Jun 10, 2021
Oneview Healthcare (ASX:ONE) has today announced a critical proof point - a 5 year contract for its recently launched cloud based offering with a major hospital client. The deal is with Victoria's largest private health service, Epworth HealthCare.
Email Jun 09, 2021
Today our silver investment Thomson Resources (ASX: TMZ) has announced a group of experts are re-analysing historical data from its multiple silver projects in order to re-model the silver resource size.
Be the first to know about our investment portfolio
Email Jun 07, 2021
Vonex (ASX: VN8) today announced a new acquisition to deliver $15.6M revenue with an EBITDA of approximately $5M in CY2020.
Alaskan oil explorer 88 Energy (ASX: 88E | OTC: EEENF) has cut a deal to buy back its 1.6 billion barrel Project Peregrine, and now holds 100% of it once again.
Email Jun 05, 2021
This week we took an in-depth look at our latest investment BPM Minerals (ASX: BPM), our 2019 Pick of the Year Elixir Energy (ASX: EXR) and Vonex Ltd (ASX: VN8) which went into a trading halt 2 hours after we launched our article...
Email Jun 04, 2021
Elixir Energy (ASX: EXR) is defining a large natural gas resource on the Mongolian-China border, with the goal to replace the burning of coal for energy in China. EXR is emerging from recent share price weakness, below is what we think happened.
Email Jun 03, 2021
BPM Minerals (ASX: BPM) today iannounced the completion of a site visit, off the back of yesterday’s key drill results from neighbour Rumble Resources.
Email Jun 01, 2021
Today Vonex Ltd (ASX: VN8) announced the successful integration of its last acquisition, hitting 45,000 PBX users and growth of SME customers and whitelabel offerings.
Be the first to find out about our next investment.
Thanks for subscribing!
